Vascular Closure Systems
Vascular Closure Systems has not claimed their Profile.
1 of Vascular Closure Systems's competitors have claimed theirs
Here’s why one competitor wins customers.
Serving our community is priority one at Fort HealthCare,
We base our product choice decisions on what is safe, how it impacts our staff and patients, and the potential for integrating with other systems to optimize the investment. The Ivenix Infusion System delivers on all of those priorities.
Top alternatives to Vascular Closure Systems
Compete with Vascular Closure Systems?
Brief our analysts.
Get in front of tech buyers.
100% free.
No pay-to-play nonsense.
Compete with Vascular Closure Systems?
Brief our analysts.
Get in front of tech buyers.
100% free.
No pay-to-play nonsense.
Compare Vascular Closure Systems to Competitors
ExploraMed is a medical technology incubation company dedicated to the identification, creation and development of medical device solutions. ExploraMed creates ideas in the fields of clinical, engineering, legal, strategic marketing, and financing, while focusing on efficient and timely development.
GRAFTcath is a medical device company developing vascular access products for hemodialysis.
Hemosphere (formerly GRAFTcath) has developed a vascular access product that has the potential to reduce the risk of bacteremia, or severe infection, posed to catheter-dependent patients undergoing hemodialysis.
Claros Diagnostics is an early stage device company developing a POC multiplex diagnostic focused on a biomarker panel for prostate cancer.
Axial Biotech, founded in 2002 by a group of spine surgeons and geneticists, is focused on the use of genetics and the development of minimally invasive fusionless devices to advance the diagnosis and treatment of diseases and deformities of the human spine. Axial is a company to pursue DNA-based pre-symptomatic and prognostic tests for common spinal conditions which will augment current clinical and surgical practices. In its initial genetic product development initiative, Axial has made progress towards the discovery of a location in the human genome that is associated with adolescent idiopathic scoliosis. In addition, Axial's founders have developed five motion preserving, fusionless surgical devices (including such device currently being implanted in humans) that have the promise of expanding the current treatable scoliosis patient population by a factor of ten. Axial intends to use its genetic intellectual property in the development of bio-mechanical devices, and to apply its gene discovery/product development methodology to other spinal diseases. Axial (www.axialbiotech.com) is located in Salt Lake City, Utah.
Endothelix, Inc. is a cardiovascular device company focused on addressing inaccurate individualized prediction of cardiovascular risk and inadequate monitoring of the vascular response to treatments.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.